Patents by Inventor Justin Weaver

Justin Weaver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210122806
    Abstract: The present application relates to a method of producing an anti-C5 antibody (ravulizumab).
    Type: Application
    Filed: June 27, 2019
    Publication date: April 29, 2021
    Inventors: Hunter F. MALANSON, Kyle A. ZINGARO, Anjil GIRI, Justin WEAVER, Abraham FRIEDMAN, Jeffrey William HUNTER, Saranya SIVANANDAM, Jeffrey ZUGATES, Rahul GODAWAT
  • Publication number: 20070196905
    Abstract: The present invention is directed to a regio- and stereoselective bioconversion of selected aliphatic dinitriles into corresponding cyanocarboxylic acids. More particularly, the present invention provides methods for the conversion of 2-isobutyl-succinonitrile into (S)-3 cyano-5-methylhexanoic acid, which is a useful intermediate in the synthesis of (S)-3(aminomethyl)-5-methylhexanoic acid (pregabalin). Pregabalin can be used for treating certain cerebral diseases, for example, in the treatment and prevention of seizure disorders, pain, and psychotic disorders.
    Type: Application
    Filed: April 1, 2005
    Publication date: August 23, 2007
    Inventors: Michael Burns, Justin Weaver, John Wong